Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Medical Oncology (Northwood, London, England)|January 25, 2011
Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancerMotohiro Tamiya, Hidekazu Suzuki, Masashi Kobayashi, et al.
BMC Pulmonary Medicine|November 27, 2020
A case report of aspergillosis accompanied by saccular bronchodilation after bronchial thermoplasty in a 19-year-old womanShinji Sasada, Kenshiro Ohmura, Tomoyo Oguri, et al.
Respirology (Carlton, Vic.)|September 29, 2012
Bronchoscopic practice in Japan: a survey by the Japan Society for Respiratory Endoscopy in 2010Fumihiro Asano, Motoi Aoe, Yoshinobu Ohsaki, et al.
Anticancer Research|November 2, 2010
Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesotheliomaHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Respirology (Carlton, Vic.)|April 17, 2013
Diagnostic yield of combined bronchoscopy and endobronchial ultrasonography, under LungPoint guidance for small peripheral pulmonary lesionsMotohiro Tamiya, Norio Okamoto, Shinji Sasada, et al.
Internal Medicine (Tokyo, Japan)|March 23, 2011
Diagnostic factors of standard bronchoscopy for small (≤15 mm) peripheral pulmonary lesions: a multivariate analysisMotohiro Tamiya, Shinji Sasada, Masashi Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 19, 2008
[Two cases of severe myelosuppression from amrubicin in previously-treated small cell lung cancer]Hidekazu Suzuki, Shinji Sasada, Yoshinobu Matsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Renal salt-wasting syndrome progressing to severe hyponatremia after chemotherapy--a case report]Hidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Medical Oncology (Northwood, London, England)|July 16, 2010
Prognosis of small-cell lung cancer since the introduction of amrubicinHidekazu Suzuki, Tomonori Hirashima, Masashi Kobayashi, et al.
Respiratory Medicine Case Reports|April 19, 2021
A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutationTomoyo Oguri, Shinji Sasada, Sachiko Seki, et al.
Pageof 9